Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Financings

Elixxer Provides Update on Secured and Unsecured Loans

ELXR · Price

Executive Summary

  • Elixxer Ltd. entered into an Amending Agreement with AIP Asset Management Inc. and AIP Convertible Private Debt Fund L.P., extending the maturity of $8 M of secured notes to June 30 2026 and an unsecured promissory note to December 31 2026.
  • The amendments are a related‑party transaction undertaken under exemptions from TSX Venture Exchange minority‑shareholder approval requirements, intended to improve the Company’s financial position.
  • The amendment was approved by all independent directors; no special committee was formed and no dissenting votes were recorded.

Key Details

  • Amending Agreement Date: January 29 2026 (effective January 1 2026).
  • Secured Notes: $8,000,000 principal amount plus accrued interest; maturity extended to June 30 2026.
  • Unsecured Promissory Note: Extended maturity to December 31 2026.
  • Counterparties: AIP Asset Management Inc. (Security Agent) and AIP Convertible Private Debt Fund L.P. (AIP Fund).
  • Related‑Party Status: AIP is a control person of Elixxer; transaction falls under TSX Venture Exchange Policy 5.9 and MI 61‑101.
  • Exemptions Relied Upon: Sections 5.5(b) and 5.7(1)(e) of MI 61‑101 (company not listed on a specified market, financial difficulty, amendments designed to improve financial position).
  • Board Approval: Approved by all independent directors (all except Alexey Kanayev and Jayahari Balasubramaniam); no special committee formed; no material dissent.
  • Regulatory Filing: No material change report filed 21 days prior; Company deemed the timing reasonable.
  • Purpose: Designed to improve Elixxer’s financial position by extending debt maturities.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from None